Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nykode Therapeutics ASA Director's Dealing 2023

Oct 27, 2023

3695_dirs_2023-10-27_47233700-8cb3-4a67-ad26-8f3d1c66f4f9.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

1 Details of the person discharging managerial responsibilities
a) Name Martin Nicklasson
b) Position Chair of the Board
2 Reason for notification
a) Initial notification/
Amendment
Initial
3 Details of issuer
a) Name Nykode Therapeutics ASA
b) LEI 254900UKQHWYZJD22017
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the
financial instrument,
type of instrument
Shares in Nykode Therapeutics ASA (ISIN: NO0010714785)
b) Nature of the
transaction
Acquisition of shares
c) Price(s) and volume(s) Price(s) Volume(s)
NOK 16.36 20,000
d) Aggregated information Price NOK 16.36
-Average price, Volume 20,000
aggregated volume and
total amount
Total amount NOK 327,200
e) Date of the transaction 27.10.2023
f) Place of the transaction XOSL - Oslo Stock Exchange